Nafamostat mesylate，又称甲磺酸萘莫司他，是一种广谱的丝氨酸蛋白酶抑制剂，也是一种抗凝血剂，能抑制血液凝固，最初是作为补体抑制剂，临床上可用于胰腺炎。

参考文献

[1] Gocho T, Uwagawa T, Furukawa K, et al. Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-κB activation for pancreatic cancer. Cancer Lett. 2013 Jun 1;333(1):89-95. doi: 10.1016/j.canlet.2013.01.019(IF:6.508).

[2] Sundaram S, Gikakis N, Hack CE, et al. Nafamostat mesilate, a broad spectrum protease inhibitor, modulates platelet, neutrophil and contact activation in simulated extracorporeal circulation. Thromb Haemost. 1996 Jan;75(1):76-82(IF:4.733).

-25~-15℃保存，有效期3年。